Clover Health Investments Corp (NASDAQ:CLOV) has a beta value of 1.93 and has seen 2.44 million shares traded in the recent trading session. The company, currently valued at $1.48B, closed the recent trade at $5890000.0 per share which meant it gained $5889996.98 on the day or 2435097% during that session. The CLOV stock price is 100.0% off its 52-week high price of $4.87 and 100.0% above the 52-week low of $1.13. If we look at the company’s 10-day average daily trading volume, we find that it stood at 6.14 million shares traded. The 3-month trading volume is 5.89 million shares.
The consensus among analysts is that Clover Health Investments Corp (CLOV) is Hold stock at the moment, with a recommendation rating of 2.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 1 have rated it as a Hold, with 0 advising it as a Buy. 0 have rated the stock as Underweight.
Clover Health Investments Corp (NASDAQ:CLOV) trade information
Over the past 30 days, the shares of Clover Health Investments Corp (NASDAQ:CLOV) have changed -17.47%. Short interest in the company has seen 20.44 million shares shorted with days to cover at 3.19.
Wall Street analysts have a consensus price target for the stock at $2.5, which means that the shares’ value could drop -235599900.0% from the levels at last check today.. The projected low price target is $1.8 while the price target rests at a high of $6.0. In that case, then, we find that the latest price level in today’s session is 100.0% off the targeted high while a plunge would see the stock lose 100.0% from the levels at last check today..
Clover Health Investments Corp (CLOV) estimates and forecasts
The company’s shares have lost -9.50% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -237.67% over the past 5 years.
CLOV Dividends
Clover Health Investments Corp is expected to release its next earnings report on 2025-May-06 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Clover Health Investments Corp (NASDAQ:CLOV)’s Major holders
Insiders own 3.90% of the company shares, while shares held by institutions stand at 26.16% with a share float percentage of 27.22%. Investors are also buoyed by the number of investors in a company, with Clover Health Investments Corp having a total of 245.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 17.35 million shares worth more than $21.33 million. As of 2024-06-30, VANGUARD GROUP INC held 3.5581% of shares outstanding.
The other major institutional holder is RENAISSANCE TECHNOLOGIES LLC, with the holding of over 11.27 million shares as of 2024-06-30. The firm’s total holdings are worth over $13.86 million and represent 2.3123% of shares outstanding.
